Application of novel base conversion editing system on gene therapy

A kind of use and coding sequence technology, applied in the field of gene editing, can solve the problems of inability to realize changes, low activity of adenine deaminase, narrow mutation window of cytosine deaminase, etc.

Active Publication Date: 2020-02-25
EAST CHINA NORMAL UNIV
View PDF5 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, in the existing research results, the gene editing system either performs C / G editing alone to T / A (cytidine deaminase), or alone performs A / T editing to G / C (adenine deaminase). enzyme), if the two systems are directly transferred into the cell at the same time, since the action sites of the two enzymes are similar, and they are fused to cas9 at the same time, then only a certain base can be realized on one allele The editing of two single bases cannot achieve two kinds of single base changes, and there are also defects that the mutation window of cytosine deaminase is too narrow (only 4-8 bases), and the activity of adenine deaminase is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of novel base conversion editing system on gene therapy
  • Application of novel base conversion editing system on gene therapy
  • Application of novel base conversion editing system on gene therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0200] Embodiment 1, the construction of the second vector or the second nucleic acid construct

[0201] 1. Target sequences derived from human loci EMX1, PD-1, VEGFA

[0202] According to the working principle of CRISPR / Cas9 and BE3, ABE7.10, in NCBI, obtain the targets where C or A simultaneously appear in the ACBE window on human loci (such as EMX1, PD-1, VEGFA), as shown in Table 1 below shown.

[0203] Table 1. Target sequences of human-derived loci EMX1, PD-1, VEGFA

[0204] target name sequence(5`-3`) EMX1-BE3-sg1 SEQ ID NO.8 AAGGACGGCGGCACCGGCGGGGG PD-1-sg1 SEQ ID NO.9 CTGCAGCTTCTCCAACACATCGG PD-1-sg2 SEQ ID NO.10 CAGCAACCAGACGGACAAGCTGG PD-1-sg3 SEQ ID NO.11 GGACCGCAGCCAGCCCGGCCAGG PD-1-sg4 SEQ ID NO.12 CTTCCACATGAGCGTGGTCAGGG VEGFA-sg2 SEQ ID NO.13 GGCGAGCCGCGGGCAGGGGCCGG

[0205] 2. Design sgRNAoligo according to the target sequence

[0206] The construction of the target plasmid (the target ...

Embodiment 2

[0220] Embodiment 2, the construction of ABE7.10 gene editing vector or nucleic acid construct

[0221] On the basis of ABE7.10 (addgene #102919), AID and Apobec1 were respectively cloned to the C-terminal of ABE7.10 by PCR, and wild TadA was cloned to the N-terminal of ABE7.10 to obtain the following Picture 1-1 and the plasmids or constructs shown in 1-2.

Embodiment 3

[0222] Example 3. Design and construction of different base conversion editing systems ACBE

[0223] 1. in Picture 1-1 with Figure 1-2 Based on the base conversion editing system, other different base conversion editing systems were designed, that is, AID and Apobec1 were respectively cloned into the C-terminal and N-terminal of ABE7. Clone a T after the C-terminus 2 A-UGI, you can get as follows figure 1 Plasmids indicated. The primers used are shown in Table 3 below:

[0224] Table 3 Primer sequences for constructing different base conversion editing systems

[0225]

[0226]

[0227] 2. Construction of U6-sgRNA-CMV-UGI-T 2 A-GFP

[0228] With the primers listed in Table 4 below, CMV, UGI, T 2 A-GFP, assembled onto U6-sgRNA(EcoRV+NotI) plasmid.

[0229] Table 4 Primer sequences for constructing different base conversion editing systems

[0230]

[0231] 3. Detection of working window and working efficiency of ACBE-N-AID and ACBE-N-Apobec1 mutant endogeno...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention innovatively provides an application of a novel base conversion editing system on gene therapy for the first time; according to the system, the function of a single-base gene editing system is reserved, which is characterized in that conversion from C / G to T / A of a single base at a specified site is realized, conversion from A / T to G / C is realized, and the conversion from C / G to T / Aand from A / T to G / C can be also realized. The basic group conversion editing system comprises sgRNA, nuclease, cytosine deaminase, adenosine deaminase and uracil glycosidase inhibitors, and the nuclease, the cytosine deaminase, the adenosine deaminase and the uracil glycosidase inhibitors can target and recognize DNA sequences. The invention further provides a pharmaceutical composition containingthe base conversion editing system and the application of the pharmaceutical composition in gene editing, gene therapy, drug screening and model animal construction.

Description

technical field [0001] The invention relates to the technical field of gene editing, in particular to the application of a novel base conversion editing system for gene therapy. Background technique [0002] Gene editing technology belongs to a new molecular biology tool for DNA sequence fixed-point transformation. It can recognize a specific paired DNA sequence under the guidance of an artificially designed RNA sequence. In addition to realizing the conversion of a single base C / G to T / A within a specific window, it can also realize the conversion of A / T to G / C, and also realize the conversion of C / G to T / A and A / T Simultaneous conversion to G / C, forming two types of base conversion, modifying the sequence of protein coding, gene transcription regulation, and non-coding RNA of this section of DNA, realizing a series of new biological function changes, which can be widely used Applications related to DNA transformation, such as the improvement of biological materials, the i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/63C12N15/113C12N15/90C12N9/22C12N15/55A61K48/00
CPCC12N15/63C12N15/113C12N15/902C12N9/22C12N9/78C12Y305/04002C12Y305/04001A61K48/0066C12N2310/10C12N2310/20
Inventor 李大力朱碧云张晓辉谢玲刘明耀
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap